An updated review on benzimidazole derivatives as potential antihypertensive agents
Keywords:
Benzimidazole, hypertension, 1H-benzimidazole, antihypertensive agents, TelmisartanAbstract
A growing number of researchers in the field of medicinal chemistry are focused on nitrogenous heterocyclic compounds. Benzimidazole scaffolds appear often in this group of heterocyclic compounds. Benzimidazole derivatives are important chemotherapeutic drugs because of their isostructural pharmacophore of naturally occurring active biomolecules. Many benzimidazole derivatives have been produced in the recent few decades, and many of these compounds have shown high bioactivity against a wide range of diseases and have bioavailability, safety, and stability profiles that are among the best in the industry. Here, we've included data on the antihypertensive properties of benzimidazole derivatives that have appeared in recent studies (2010–2022), along with a structure-activity link for each. Human studies are underway for a number of intriguing therapeutic candidates, and some of them will be authorized for use in clinical settings. In order to gather the information on proposed topic all the scientific search engines and publisher sites were used such as Google scholar, Science direct, Bentham science, PubChem, PubMed, Tayler and Francis, Hindawi, Springer nature, and ACS websites. The present review provides a detailed insight of benzimidazole derivatives reported as antihypertensive agents.
Downloads
References
Abou-Seri, S. M., Abouzid, K., & Abou El Ella, D. A. (2011). Molecular modeling study and synthesis of quinazolinone-arylpiperazine derivatives as α 1-adrenoreceptor antagonists. European Journal of Medicinal Chemistry, 46(2), 647–658. https://doi.org/10.1016/j.ejmech.2010.11.045
Alaqeel, S. I. (2017). Synthetic approaches to benzimidazoles from o-phenylenediamine: A literature review. Journal of Saudi Chemical Society, 21(2), 229–237. https://doi.org/10.1016/j.jscs.2016.08.001
Bansal, Y., & Silakari, O. (2012). The therapeutic journey of benzimidazoles: A review. Bioorganic and Medicinal Chemistry, 20(21), 6208–6236. https://doi.org/10.1016/j.bmc.2012.09.013
Bao, X. L., Zhu, W. B., Shan, T. L., Wu, Z., Zhang, R. J., Liao, P. Y., Zheng, M. Z., Tang, H. S., Yan, Y. J., & Chen, Z. L. (2017). Design, synthesis and evaluation of novel angiotensin II receptor 1 antagonists with antihypertensive activities. RSC Advances, 7(42), 26401–26410. https://doi.org/10.1039/c7ra03915h
Barot, K., Nikolova, S., Ivanov, I., & Ghate, M. (2013). Novel Research Strategies of Benzimidazole Derivatives: A Review. Mini-Reviews in Medicinal Chemistry, 13(10), 1421–1447. https://doi.org/10.2174/13895575113139990072
Brink, N. G., & Folkers, K. (1949). Vitamin B12. VI. 5,6-dimethylbenzimidazole, a degradation product of vitamin B12. Journal of the American Chemical Society, 71(8), 2951. https://doi.org/10.1021/ja01176a532
Brishty, S. R., Hossain, M. J., Khandaker, M. U., Faruque, M. R. I., Osman, H., & Rahman, S. M. A. (2021). A Comprehensive Account on Recent Progress in Pharmacological Activities of Benzimidazole Derivatives. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.762807
Datani, R. H., Kini, S. G., Mubeen, M., Methods, J. C., & Des, M. (2012). Design , Synthesis and Vasorelaxant activity of 5-Nitro Benzimidazole Derivatives Available online a t www.scholarsresearchlibrary.com. Journal of Computational Methods in Molecular Design, 2(4), 149–157.
Fei, F., & Zhou, Z. (2013). New substituted benzimidazole derivatives: A patent review (2010-2012). Expert Opinion on Therapeutic Patents, 23(9), 1157–1179. https://doi.org/10.1517/13543776.2013.800857
Hao, L. P., Xue, W. Z., Han, X. F., He, X., Zhang, J., & Zhou, Z. M. (2015). Design, synthesis and biological activity of 4′-[(benzimidazol-1-yl)methyl]biphenyl-2-sulphonamides as dual angiotensin II and endothelin A receptor antagonists. MedChemComm, 6(4), 715–718. https://doi.org/10.1039/c4md00499j
Keri, R. S., Hiremathad, A., Budagumpi, S., & Nagaraja, B. M. (2015). Comprehensive review in current developments of benzimidazole-based medicinal chemistry. Chemical Biology and Drug Design, 86(1), 799–845. https://doi.org/10.1111/cbdd.12462
Khan, M. T., Razi, M. T., Jan, S. U., Mukhtiar, M., Gul, R., IzharUllah, Hussain, A., Hashmi, A. M., Ahmad, M. T., Shahwani, N. A., & Rabbani, I. (2018). Synthesis, characterization and antihypertensive activity of 2-phenyl substituted benzimidazoles. Pakistan Journal of Pharmaceutical Sciences, 31(3), 1067–1074.
Khan, S., Kale, M., Siddiqui, F., & Nema, N. (2021). Novel pyrimidine-benzimidazole hybrids with antibacterial and antifungal properties and potential inhibition of SARS-CoV-2 main protease and spike glycoprotein. Digital Chinese Medicine, 4(2), 102–119. https://doi.org/10.1016/j.dcmed.2021.06.004
Khan, S. L., Sonwane, G. M., Siddiqui, F. A., Jain, S. P., Kale, M. A., & Borkar, V. S. (2020). Discovery of Naturally Occurring Flavonoids as Human Cytochrome P450 (CYP3A4) Inhibitors with the Aid of Computational Chemistry. Indo Global Journal of Pharmaceutical Sciences, 10(04), 58–69. https://doi.org/10.35652/igjps.2020.10409
Kusumoto, K., Igata, H., Ojima, M., Tsuboi, A., Imanishi, M., Yamaguchi, F., Sakamoto, H., Kuroita, T., Kawaguchi, N., Nishigaki, N., & Nagaya, H. (2011). Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models. European Journal of Pharmacology, 669(1–3), 84–93. https://doi.org/10.1016/j.ejphar.2011.07.014
Lamotte, Y., Faucher, N., Sançon, J., Pineau, O., Sautet, S., Fouchet, M. H., Beneton, V., Tousaint, J. J., Saintillan, Y., Ancellin, N., Nicodeme, E., Grillot, D., & Martres, P. (2014). Discovery of novel indazole derivatives as dual angiotensin II antagonists and partial PPARγ agonists. Bioorganic and Medicinal Chemistry Letters, 24(4), 1098–1103. https://doi.org/10.1016/j.bmcl.2014.01.004
Mayura, K., Sharuk, K., & Jyoti, H. (2019). Investigating Structural Requirements of Some Pyrimidine-linked Benzimidazole Derivatives as Anticancer Agents Against MCF-7 Cancerous Cell Line Through the use of 2D and 3D QSARs. Current Chemical Biology, 13(3), 232–249. https://doi.org/10.2174/2212796813666190207144407
Morais, G. R., Palma, E., Marques, F., Gano, L., Oliveira, M. C., Abrunhosa, A., Miranda, H. V., Outeiro, T. F., Santos, I., & Paulo, A. (2017). Synthesis and Biological Evaluation of Novel 2-Aryl Benzimidazoles as Chemotherapeutic Agents. Journal of Heterocyclic Chemistry, 54(1), 255–267. https://doi.org/10.1002/jhet.2575
Sharma, M. C., Kohli, D. V., & Sharma, S. (2010). Benzimidazoles derivatives with (2-{6-Chloro-5-nitro-1-[2-(1H-tetrazol-5-yl) biphenyl-4-ylmethyl] 1H-benzoimidazol-2-yl}-phenyl)-(substituted-benzylidene)-amine with potential angiotensin II receptor antagonists as antihypertensive activity. International Journal of Drug Delivery, 2(3), 228–237. https://doi.org/10.5138/ijdd.2010.0975.0215.02033
Shntaif, A. H., Khan, S., Tapadiya, G., Chettupalli, A., Saboo, S., Shaikh, M. S., Siddiqui, F., & Amara, R. R. (2021). Rational drug design, synthesis, and biological evaluation of novel N-(2-arylaminophenyl)-2,3-diphenylquinoxaline-6-sulfonamides as potential antimalarial, antifungal, and antibacterial agents. Digital Chinese Medicine, 4(4), 290–304. https://doi.org/10.1016/j.dcmed.2021.12.004
Siddiqui, F. A., Khan, S. L., Marathe, R. P., & Nema, N. V. (2021). Design, Synthesis, and In Silico Studies of Novel N-(2-Aminophenyl)-2,3- Diphenylquinoxaline-6-Sulfonamide Derivatives Targeting Receptor- Binding Domain (RBD) of SARS-CoV-2 Spike Glycoprotein and their Evaluation as Antimicrobial and Antimalarial Agents. Letters in Drug Design & Discovery, 18(9), 915–931. https://doi.org/10.2174/1570180818666210427095203
Wang, M., Han, X., & Zhou, Z. (2015). New substituted benzimidazole derivatives: A patent review (2013-2014). Expert Opinion on Therapeutic Patents, 25(5), 595–612. https://doi.org/10.1517/13543776.2015.1015987
Woolley, D. W. (1944). Some Biological Effects Produced By Benzimidazole and Their Reversal By Purines. Journal of Biological Chemistry, 152(2), 225–232. https://doi.org/10.1016/s0021-9258(18)72045-0
Wu, Z., Xia, M. B., Bertsetseg, D., Wang, Y. H., Bao, X. L., Zhu, W. B., Tao-Xu, Chen, P. R., Tang, H. S., Yan, Y. J., & Chen, Z. L. (2020). Design, synthesis and biological evaluation of novel fluoro-substituted benzimidazole derivatives with anti-hypertension activities. Bioorganic Chemistry, 101. https://doi.org/10.1016/j.bioorg.2020.104042
Yang, C., Balsells, J., Chu, H. D., Cox, J. M., Crespo, A., Ma, X., Contino, L., Brown, P., Gao, S., Zamlynny, B., Wiltsie, J., Clemas, J., Lisnock, J., Gibson, J., Zhou, G., Garcia-Calvo, M., Bateman, T. J., Tong, V., Xu, L., … Shen, H. C. (2015). Discovery of benzimidazole oxazolidinediones as novel and selective nonsteroidal mineralocorticoid receptor antagonists. ACS Medicinal Chemistry Letters, 6(4), 461–465. https://doi.org/10.1021/acsmedchemlett.5b00010
Yang, Y., Zhang, S., Zhou, Q., Zhang, C., Gao, Y., Wang, H., Li, Z., Wu, D., Wu, Y., Huang, Y. Y., Guo, L., & Luo, H. Bin. (2020). Discovery of highly selective and orally available benzimidazole-based phosphodiesterase 10 inhibitors with improved solubility and pharmacokinetic properties for treatment of pulmonary arterial hypertension. Acta Pharmaceutica Sinica B, 10(12), 2339–2347. https://doi.org/10.1016/j.apsb.2020.04.003
Zhu, W., Da, Y., Wu, D., Zheng, H., Zhu, L., Wang, L., Yan, Y., & Chen, Z. (2014). Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities. Bioorganic and Medicinal Chemistry, 22(7), 2294–2302. https://doi.org/10.1016/j.bmc.2014.02.008
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
